180 related articles for article (PubMed ID: 36756157)
1.
Ouyang T; Ma C; Zhao Y; Ye W; Zhao J; Cai R; Zhang H; Zheng P; Lin Y
Front Oncol; 2023; 13():1082841. PubMed ID: 36756157
[TBL] [Abstract][Full Text] [Related]
2.
Ye W; Lin Y; Bezabeh T; Ma C; Liang J; Zhao J; Ouyang T; Tang W; Wu R
NMR Biomed; 2021 Jun; 34(6):e4505. PubMed ID: 33783927
[TBL] [Abstract][Full Text] [Related]
3. Exploring potential biomarkers of early stage esophageal squamous cell carcinoma in pre- and post-operative serum metabolomic fingerprint spectrum using
Yang Z; Liu Y; Ma L; Wen X; Ji H; Li K
Am J Transl Res; 2019; 11(2):819-831. PubMed ID: 30899382
[TBL] [Abstract][Full Text] [Related]
4. A multi-platform metabolomics reveals possible biomarkers for the early-stage esophageal squamous cell carcinoma.
Zhao J; Zhao X; Yu J; Gao S; Zhang M; Yang T; Liu L
Anal Chim Acta; 2022 Aug; 1220():340038. PubMed ID: 35868700
[TBL] [Abstract][Full Text] [Related]
5.
Liu YY; Yang ZX; Ma LM; Wen XQ; Ji HL; Li K
PeerJ; 2019; 7():e8151. PubMed ID: 31803539
[TBL] [Abstract][Full Text] [Related]
6. Tissue-based metabolomics reveals metabolic biomarkers and potential therapeutic targets for esophageal squamous cell carcinoma.
Chen Z; Gao Y; Huang X; Yao Y; Chen K; Zeng S; Mao W
J Pharm Biomed Anal; 2021 Apr; 197():113937. PubMed ID: 33609949
[TBL] [Abstract][Full Text] [Related]
7. Untargeted Metabolomics Analysis of Esophageal Squamous Cell Carcinoma Discovers Dysregulated Metabolic Pathways and Potential Diagnostic Biomarkers.
Zhu ZJ; Qi Z; Zhang J; Xue WH; Li LF; Shen ZB; Li ZY; Yuan YL; Wang WB; Zhao J
J Cancer; 2020; 11(13):3944-3954. PubMed ID: 32328198
[No Abstract] [Full Text] [Related]
8. Untargeted serum metabolomics reveals potential biomarkers and metabolic pathways associated with the progression of gastroesophageal cancer.
Che J; Zhao Y; Gu B; Li S; Li Y; Pan K; Sun T; Han X; Lv J; Zhang S; Fan B; Li C; Wang C; Wang J; Zhang T
BMC Cancer; 2023 Dec; 23(1):1238. PubMed ID: 38102546
[TBL] [Abstract][Full Text] [Related]
9. Untargeted metabolomics analysis of esophageal squamous cell cancer progression.
Yang T; Hui R; Nouws J; Sauler M; Zeng T; Wu Q
J Transl Med; 2022 Mar; 20(1):127. PubMed ID: 35287685
[TBL] [Abstract][Full Text] [Related]
10. Nuclear magnetic resonance-based metabolomics and metabolic pathway networks from patient-matched esophageal carcinoma, adjacent noncancerous tissues and urine.
Liang JH; Lin Y; Ouyang T; Tang W; Huang Y; Ye W; Zhao JY; Wang ZN; Ma CC
World J Gastroenterol; 2019 Jul; 25(25):3218-3230. PubMed ID: 31333313
[TBL] [Abstract][Full Text] [Related]
11. Serum Metabolomics for Biomarker Screening of Esophageal Squamous Cell Carcinoma and Esophageal Squamous Dysplasia Using Gas Chromatography-Mass Spectrometry.
Zhang S; Lu X; Hu C; Li Y; Yang H; Yan H; Fan J; Xu G; Abnet CC; Qiao Y
ACS Omega; 2020 Oct; 5(41):26402-26412. PubMed ID: 33110968
[TBL] [Abstract][Full Text] [Related]
12. Combined Metabolomic Analysis of Plasma and Tissue Reveals a Prognostic Risk Score System and Metabolic Dysregulation in Esophageal Squamous Cell Carcinoma.
Chen Z; Dai Y; Huang X; Chen K; Gao Y; Li N; Wang D; Chen A; Yang Q; Hong Y; Zeng S; Mao W
Front Oncol; 2020; 10():1545. PubMed ID: 32984013
[No Abstract] [Full Text] [Related]
13. Urinary protein biomarker panel predicts esophageal squamous carcinoma from control cases and other tumors.
Ji L; Wang J; Yang B; Zhu J; Wang Y; Jiao J; Zhu K; Zhang M; Zhai L; Gong T; Sun C; Qin J; Wang G
Esophagus; 2022 Oct; 19(4):604-616. PubMed ID: 35792948
[TBL] [Abstract][Full Text] [Related]
14. Lactation-related metabolic mechanism investigated based on mammary gland metabolomics and 4 biofluids' metabolomics relationships in dairy cows.
Sun HZ; Shi K; Wu XH; Xue MY; Wei ZH; Liu JX; Liu HY
BMC Genomics; 2017 Dec; 18(1):936. PubMed ID: 29197344
[TBL] [Abstract][Full Text] [Related]
15. Global and targeted metabolomics of esophageal squamous cell carcinoma discovers potential diagnostic and therapeutic biomarkers.
Xu J; Chen Y; Zhang R; Song Y; Cao J; Bi N; Wang J; He J; Bai J; Dong L; Wang L; Zhan Q; Abliz Z
Mol Cell Proteomics; 2013 May; 12(5):1306-18. PubMed ID: 23397110
[TBL] [Abstract][Full Text] [Related]
16. Global metabolomics reveals potential urinary biomarkers of esophageal squamous cell carcinoma for diagnosis and staging.
Xu J; Chen Y; Zhang R; He J; Song Y; Wang J; Wang H; Wang L; Zhan Q; Abliz Z
Sci Rep; 2016 Oct; 6():35010. PubMed ID: 27725730
[TBL] [Abstract][Full Text] [Related]
17. Metabolomic Characterization Reveals ILF2 and ILF3 Affected Metabolic Adaptions in Esophageal Squamous Cell Carcinoma.
Zang B; Wang W; Wang Y; Li P; Xia T; Liu X; Chen D; Piao HL; Qi H; Ma Y
Front Mol Biosci; 2021; 8():721990. PubMed ID: 34568427
[TBL] [Abstract][Full Text] [Related]
18. New Metabolic Alterations and A Predictive Marker Pipecolic Acid in Sera for Esophageal Squamous Cell Carcinoma.
Liu L; Wu J; Shi M; Wang F; Lu H; Liu J; Chen W; Yu G; Liu D; Yang J; Luo Q; Ni Y; Jin X; Jin X; Chen WL
Genomics Proteomics Bioinformatics; 2022 Aug; 20(4):670-687. PubMed ID: 35351627
[TBL] [Abstract][Full Text] [Related]
19. Development of a panel of autoantibody against NSG1 with CEA, CYFRA21-1, and SCC-Ag for the diagnosis of esophageal squamous cell carcinoma.
Zheng Q; Zhang L; Tu M; Yin X; Cai L; Zhang S; Yu L; Pan X; Huang Y
Clin Chim Acta; 2021 Sep; 520():126-132. PubMed ID: 34119530
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]